Outsourcing

It is important to understand degradation and processing to maintain product stability in biologics.

Is there enough talent to go around?

MedImmune will provide funds and access to monoclonal antibodies to seven postdoctoral associates for the creation of protein measurement and characterization tools.

The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.

The draft guidance contains policies for drugs that are processed with additional manufacturing steps such as remixing, dilution, and repackaging.

The agency releases five draft guidance documents related to drug compounding and repackaging.

The new center represents AmerisourceBergen’s first facility erected specifically for clinical trial and commercial third-party logistics activities.

Market forces may limit the success of CMOs.

Nelson Patterson has been elected to Pharma & Biopharma Outsourcing Association board.

There are significant differences between small molecules and biologics fill/finish capacity.

Ligand-binding assays are fundamental to characterizing biosimilars.

Biomanufacturing capacity expansion uses modular cleanroom design and single-use technologies.

New organization offers support to contract research organizations and contract manufacturing organizations in the New England area.

Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.

Grand River Aseptic Manufacturing has announced that the company executed two commercial production contracts in one day.

European CDMOs want into the US market, but entry options are limited.

The trend of exits from the CMO industry looks to be gaining momentum.

A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.

A Q&A on bioanalytical method integrity with Roger Hayes of MPI Research.

Representatives of contract service organizations discuss technology trends with BioPharm International.

Annual study shows geographic proximity not a factor in CMO selection.

A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.

The author highlights the top 10 outsourcing trends found during a survey of biopharmaceutical manufacturers.

As payers refuse to cover new drugs, CMOs take a hit.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China's Food and Drug Administration's shortened serialization deadline.